Dr. Soliman Abdel Kader Fakeeh Hospital Company

SASE:4017 Stock Report

Market Cap: ر.س13.5b

Dr. Soliman Abdel Kader Fakeeh Hospital Future Growth

Future criteria checks 3/6

Dr. Soliman Abdel Kader Fakeeh Hospital is forecast to grow earnings and revenue by 19.7% and 16.5% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 12.9% in 3 years.

Key information

19.7%

Earnings growth rate

18.3%

EPS growth rate

Healthcare earnings growth14.8%
Revenue growth rate16.5%
Future return on equity12.9%
Analyst coverage

Low

Last updated02 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SASE:4017 - Analysts future estimates and past financials data (SAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,027462-885575
12/31/20253,408372-5014275
12/31/20242,830285-7183215
6/30/20242,586274-29251N/A
3/31/20242,478280123373N/A
12/31/20232,327280-72304N/A
9/30/20232,205311-28289N/A
12/31/20222,012326-138-15N/A
12/31/20211,965334172255N/A
12/31/20201,715203-634N/A
12/31/20191,640301-323-196N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4017's forecast earnings growth (19.7% per year) is above the savings rate (14.5%).

Earnings vs Market: 4017's earnings (19.7% per year) are forecast to grow faster than the SA market (7.2% per year).

High Growth Earnings: 4017's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4017's revenue (16.5% per year) is forecast to grow faster than the SA market (1.2% per year).

High Growth Revenue: 4017's revenue (16.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4017's Return on Equity is forecast to be low in 3 years time (12.9%).


Discover growth companies